PharmSci 360

Registration information coming Spring 2023!

Call for Programming is now open!

Read More!

Sponsorship opportunities and exhibitor information.

Read More!

2023 PharmSci 360 Scientific Programming Committee

Otilia Koo, Ph.D., BMS (Chair)

Amit Desai, Ph.D., Astellas Pharma (Vice-Chair)

Kevin Litwilier, Ph.D., OnKure Therapeutics  (Past Chair)

Discovery and Basic Research Track

Patrick Ronaldson, Ph.D., University of Arizona College of Medicine (Track Chair)

Carsten Ehrhardt, Ph.D., Trinity College Dublin (Sub-Track Leader)

Sudip Das, MPharm, Ph.D., Butler University (Sub-Track Leader)

Preclinical and Translational Sciences Track

Yurong Lai, Ph.D., Gilead Sciences Inc. (Track Chair)

Jaya Vaidyanathan, Ph.D., US FDA (Sub-Track Leader)

Fei Hua, Ph.D., Applied BioMath (Sub-Track Leader)

Bioanalytics Track

Catherine Vrentas, Ph.D., MBA, PPD (Track Chair)

Catherine Brockus, Ph.D., Eli Lilly and Company (Sub-Track Leader)

Long Yuan, Ph.D., Biogen (Sub-Track Leader)

Manufacturing and Analytical Characterization Track

Sayantan Chattoraj, Ph.D., GlaxoSmithKline (Track Chair)

Thilak Mudalige, Ph.D., US FDA (Sub-Track Leader)

Fengqiang Wang, Ph.D., Merck (Sub-Track Leader)

Formulation and Delivery Track

Xiuling Lu, Ph.D., University of Connecticut (Track Chair)

Mary Krause, Ph.D., Bristol Myers Squibb (Sub-Track Leader)

Heidi Mansour, Ph.D., R.Ph., Florida International University (Sub-Track Leader)